Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.
You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.
Other companies in Cellectar Biosciences’s space includes: CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Citius Oncology (NASDAQ:CTOR), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).
Cellectar Biosciences has a consensus price target of $15.33.
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $2.1 last updated November 14, 2024 at 9:29 AM EST.
There are no upcoming dividends for Cellectar Biosciences.
Cellectar Biosciences’s Q3 earnings are confirmed for Monday, November 18, 2024.
There is no upcoming split for Cellectar Biosciences.
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.